NEUCA S.A. (NEU.WA) is currently considered halal (Sharia-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.
Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. NEU.WA files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.
Business activity: cleared (no excluded categories detected)
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 20.22% | 30.00% | Pass |
| Interest-bearing investments | 4.90% | 30.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 11.15% | 33.00% | Pass |
| Interest-bearing investments | 2.70% | 33.00% | Pass |
| Non-liquid assets | 65.22% | at least 20.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 11.15% | 33.33% | Pass |
| Cash + interest-bearing securities | 2.70% | 33.33% | Pass |
| Accounts receivable | 34.78% | 33.33% | Fail |
| Non-permissible income | 0.18% | 5.00% | Pass |
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 11.15% | 33.33% | Pass |
| Cash + interest-bearing securities | 2.70% | 33.33% | Pass |
| Accounts receivable | 34.78% | 50.00% | Pass |
| Non-permissible income | 0.18% | 5.00% | Pass |
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 21.48% | 33.00% | Pass |
| Cash + interest-bearing securities | 5.20% | 33.00% | Pass |
| Accounts receivable | 61.80% | 33.00% | Fail |
| Non-permissible income | 0.18% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 21.03% | 33.00% | Pass |
| Cash + interest-bearing securities | 5.09% | 49.00% | Pass |
| Accounts receivable | 60.49% | 49.00% | Fail |
| Non-permissible income | 0.18% | 5.00% | Pass |
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 21.03% | 33.33% | Pass |
| Cash + interest-bearing securities | 5.09% | 33.33% | Pass |
| Accounts receivable | 65.58% | 49.00% | Fail |
| Non-permissible income | 0.18% | 5.00% | Pass |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 51.30 | NEUTRAL |
| Stochastic %K (14) | 43.94 | NEUTRAL |
| CCI (20) | -79.49 | NEUTRAL |
| Williams %R (14) | -56.06 | NEUTRAL |
| MACD (12,26,9) | -3.35 | SELL |
| ROC (10) | -3.15 | SELL |
| Momentum (10) | -25.00 | SELL |
| EMA (10) | 767.43 | BUY |
| SMA (10) | 771.00 | SELL |
| EMA (20) | 768.70 | BUY |
| SMA (20) | 769.55 | BUY |
| EMA (30) | 765.64 | BUY |
| SMA (30) | 775.30 | SELL |
| EMA (50) | 756.67 | BUY |
| SMA (50) | 755.52 | BUY |
| EMA (100) | 742.17 | BUY |
| SMA (100) | 729.29 | BUY |
| EMA (200) | 741.53 | BUY |
| SMA (200) | 741.08 | BUY |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Medical Distribution
NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic and dressing materials under the Swiat Zdrowia, APTEO, GENOPTIM, CERA+ Solutions, and Kic Kic brands. It also provides medical care services, including prevention, diagnostics, treatment, and complementary services; and financing services, such as insurance, subscriptions, occupational medicine, preventive and medicine programmes, FFS, NFZ, public, private, and corporate payer services. In addition, the company offers TPA services, remote consultations, in person visits, diagnostic tests, and occupational medicine services; operates a medical helpline and medical facilities; and offers medicine through apteline.pl, an e-commerce medical ordering site. Further, it engages in running clinical trials in the field of outsourcing clinical research and conducting clinical research centres; provision of insurance products, including health insurance products. Additionally, the company provides advertising and marketing services to pharmaceutical market entities; and logistics services for pharmaceutical manufacturers. The company was formerly known as Torfarm SA and changed its name to NEUCA S.A. in April 2010. NEUCA S.A. was founded in 1990 and is based in Torun, Poland.
Background via Yahoo Finance — informational, not part of the verdict.
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-08 · Asset managers net 912361 (-21819)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.